[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ZA978226B - Fatty acid treatment. - Google Patents

Fatty acid treatment.

Info

Publication number
ZA978226B
ZA978226B ZA9708226A ZA978226A ZA978226B ZA 978226 B ZA978226 B ZA 978226B ZA 9708226 A ZA9708226 A ZA 9708226A ZA 978226 A ZA978226 A ZA 978226A ZA 978226 B ZA978226 B ZA 978226B
Authority
ZA
South Africa
Prior art keywords
fatty acid
acid treatment
treatment
fatty
acid
Prior art date
Application number
ZA9708226A
Inventor
David Frederick Horrobin
Catherine Ann Scott
Original Assignee
Scotia Holdings Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scotia Holdings Plc filed Critical Scotia Holdings Plc
Publication of ZA978226B publication Critical patent/ZA978226B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA9708226A 1996-10-14 1997-09-12 Fatty acid treatment. ZA978226B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9621373.1A GB9621373D0 (en) 1996-10-14 1996-10-14 Fatty acid treatment

Publications (1)

Publication Number Publication Date
ZA978226B true ZA978226B (en) 1998-05-11

Family

ID=10801378

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9708226A ZA978226B (en) 1996-10-14 1997-09-12 Fatty acid treatment.

Country Status (4)

Country Link
AU (1) AU4130597A (en)
GB (1) GB9621373D0 (en)
WO (1) WO1998016215A1 (en)
ZA (1) ZA978226B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2704975A1 (en) * 1999-10-13 2001-05-31 Marco A. Chacon Therapeutic intervention to mimic the effect of caloric restriction
US20020188024A1 (en) * 2000-08-23 2002-12-12 Chilton Floyd H. Fatty acid-containing emulsion with increased bioavailability
US8092839B2 (en) 2004-12-13 2012-01-10 Swing Aerobics Licensing, Inc. Medicament for treatment of cancer and other diseases
US8431165B2 (en) 2004-12-13 2013-04-30 Swing Aerobics Licensing, Inc. Medicament for treatment of cancer and other diseases
GB0907413D0 (en) 2009-04-29 2009-06-10 Equateq Ltd Novel methods
BR112013000108B1 (en) 2010-07-22 2021-05-11 Unilever Ip Holdings B.V. detergent composition, its uses, and process for cleaning a substrate
US8293790B2 (en) 2011-10-19 2012-10-23 Dignity Sciences Limited Pharmaceutical compositions comprising DGLA and benzoyl peroxide and methods of use thereof
MX2016015961A (en) 2014-06-04 2017-04-05 Dignity Sciences Ltd Pharmaceutical compositions comprising dgla and use of same.
CN108741081A (en) * 2018-06-29 2018-11-06 许昌元化生物科技有限公司 One kind containing linolenic composite micro-powder and preparation method thereof
US20210315851A1 (en) 2020-04-03 2021-10-14 Afimmune Limited Compositions comprising 15-hepe and methods of treating or preventing hematologic disorders, and/or related diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58180423A (en) * 1982-04-16 1983-10-21 Nippon Suisan Kaisha Ltd Remedy for peripheral blood stream disorder
GB8920228D0 (en) * 1989-09-07 1989-10-18 Efamol Holdings Fatty acid therapy
GB9301446D0 (en) * 1993-01-26 1993-03-17 Scotia Holdings Plc Internal radiation damage

Also Published As

Publication number Publication date
AU4130597A (en) 1998-05-11
GB9621373D0 (en) 1996-12-04
WO1998016215A1 (en) 1998-04-23

Similar Documents

Publication Publication Date Title
ZA977902B (en) Fatty acid treatment
ZA974523B (en) Endoscopes.
ZA99567B (en) Aryl-acrylic acid esters.
GB9626637D0 (en) Percarboxyilic acid solutions
ZA978226B (en) Fatty acid treatment.
ZA972515B (en) Acne treatment.
ZA978359B (en) Novel treatment
AU3176595A (en) Fatty acid treatment
ZA976593B (en) Novel treatment
ZA977867B (en) Method of treatment.
GB9608657D0 (en) Novel treatment
ZA979052B (en) Fatty acid treatment.
GB2322785B (en) Pasteurizing process
GB9625795D0 (en) Novel treatment
ZA957903B (en) Fatty acid treatment
GB9515185D0 (en) Fatty acid treatment
GB9612752D0 (en) Novel treatment
ZA976429B (en) Benzoylpropionic acid ester derivatives.
GB9605166D0 (en) Acid treatment process
GB9605167D0 (en) Acid treatment process
GB9617762D0 (en) Treatment
KR0137670B1 (en) 5-METHYL-5-0-(Ñß-D-GLUCOPYRANOSYL)-D-ERYTHROASCORBIC ACID
GB9616407D0 (en) Novel treatment
GB9610986D0 (en) Novel treatment
GB9616410D0 (en) Novel treatment